MNK News and Press, Mallinckrodt plc From 10/24/22

Mallinckrodt ( NYSE: MNK ) has gained approval to list its ordinary shares on NYSE American. The ordinary shares of the specialty pharmaceutical company are expected to commence trading on NYSE American under the ticker symbol "MNK" from October 27, 2022. Trading on the OT...

Mallinckrodt Receives Approval to List on NYSE American PR Newswire Trading on NYSE American Expected to Commence Under Ticker Symbol "MNK" on October 27, 2022 DUBLIN , Oct. 24, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF) (" M...

Mallinckrodt Announces Appointment of Susan Silbermann to its Board of Directors PR Newswire DUBLIN , Oct. 6, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF) (" Mallinckrodt " or the "Company"), a global specialty pharmaceutical company, to...

The U.S. Food and Drug Administration (FDA) approved Mallinckrodt's ( NYSE: MNK ) ( OTCPK:MNKPF ) Terlivaz (terlipressin) injection to improve kidney function in adults with hepatorenal syndrome (HRS) with rapid reduction in kidney function. HRS involves reduc...

Mallinckrodt Receives U.S. FDA Approval for Terlivaz® (terlipressin) for injection for the Treatment of Hepatorenal Syndrome (HRS) PR Newswire – Terlivaz is the first and only FDA-approved treatment for adults with HRS involving rapid reduction in kidney func...

Summary Founded in 2006 by Morty Schaja and Mitch Rubin, RiverPark manages research-driven, focused strategies in equities, fixed income and venture capital. Currently, investors are caught in an economic “No Man’s Land” between the dangers of inflation and fe...

Mallinckrodt plc (MNK) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Daniel Speciale - Global Corporate Controller & Chief IR Officer Sigurdur Olafsson - President & CEO Bryan Reasons - Chief Financial Officer Conf...

Mallinckrodt press release ( NYSE: MNK ): Q2 net loss of $257.2M Revenue of $468.7M (-14.2% Y/Y). Bryan Reasons, EVP and Chief Financial Officer, said, "Having eliminated more than $1.3 billion in debt principal and closed a new $200 million accounts receivable financi...

Major earnings expected before the bell on Thursday include: Arrival ( ARVL ) Brookfield Asset Management ( BAM ) Cardinal Health ( CAH ) Hanesbrands ( HBI ) Himax Technologies ( HIMX ) For further details see: Notable earnings before Thur...

Mallinckrodt to Present Data on Terlipressin in Adult Patients with Hepatorenal Syndrome (HRS) at the European Association for the Study of the Liver (EASL) 2022 International Liver Congress PR Newswire -Post-hoc analyses showcase Mallinckrodt's commitment to patie...